MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies ...
Includes issuance of shares underlying warrants originally issued in 2021, earnout shares previously registered on recent Registration Statement on Form S-4, and the resale of shares that are ...
ABL Bio Inc. has submitted an IND application to the FDA seeking clearance to begin a phase I trial of ABL-209 (NEOK-002).
Tevogen Bio files additional AI-related patent to enhance drug discovery and develops T cell therapies for infectious diseases and cancers. Tevogen Bio, a clinical-stage biotech company specializing ...
Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...
Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware, according to a court filing. The California-based biotech intends to use the court-administered restructuring ...
Local life science startup Boundless Bio filed Wednesday to go public — the first San Diego biotech to do so this year. It is the first initial public offering, or IPO, by a local life science firm in ...
James M. Wilson, MD, PhD, director of the Gene Therapy Program at the University of Pennsylvania, and a co-founder of Passage Bio. Passage Bio, a developer of gene therapies for rare monogenic CNS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results